Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
ALK positive
Cancer:
Peripheral T-cell Lymphoma
Drug:
Alunbrig (brigatinib)
(
EGFR inhibitor
,
ALK inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Published date:
12/21/2023
Excerpt:
Peripheral T-Cell Lymphomas: SUGGESTED TREATMENT REGIMENS ALCL…ALK inhibitors (for ALK-positive ALCL only)…Brigatinib…
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login